v3.26.3
Notes to the unaudited interim condensed consolidated statement of financial position - Stock Options (SO) (Details)
6 Months Ended
Jun. 30, 2026
EUR (€)
shares
plan
Jun. 09, 2026
EUR (€)
shares
Jun. 30, 2026
EUR (€)
plan
shares
Jun. 30, 2026
EUR (€)
plan
€ / shares
shares
Jun. 30, 2026
EUR (€)
plan
shares
Jun. 30, 2026
EUR (€)
Options
plan
shares
Jun. 30, 2026
EUR (€)
plan
shares
Jun. 30, 2026
EUR (€)
Y
plan
shares
Jan. 26, 2026
EUR (€)
Dec. 04, 2025
EUR (€)
Oct. 10, 2025
EUR (€)
Jan. 23, 2025
EUR (€)
Shareholders' equity                        
Outstanding at beginning of period           22,122,366            
Issued           4,067,000            
Forfeited/Lapsed           (7,500)            
Outstanding at end of period 26,181,866         26,181,866            
Stock options                        
Shareholders' equity                        
Number of plans outstanding | plan 7   7 7 7 7 7 7        
Share-based compensation expense | €         € 7,300,000              
SO 2024-1                        
Shareholders' equity                        
Fair value per SO at grant date | €                       € 1.1
Outstanding at beginning of period           12,898,116            
Outstanding at end of period           12,898,116            
Implied stock options fair values | € € 14,200,000   € 14,200,000 € 14,200,000 14,200,000 € 14,200,000 € 14,200,000 € 14,200,000        
SO 2024-2                        
Shareholders' equity                        
Fair value per SO at grant date | €                       € 1.1
Outstanding at beginning of period           213,000            
Outstanding at end of period           213,000            
Implied stock options fair values | € 200,000   200,000 200,000 200,000 € 200,000 200,000 200,000        
SO 2025-1                        
Shareholders' equity                        
Fair value per SO at grant date | €                     € 1.77  
Outstanding at beginning of period           1,865,750            
Forfeited/Lapsed           (7,500)            
Outstanding at end of period           1,858,250            
Implied stock options fair values | € 3,300,000   3,300,000 3,300,000 3,300,000 € 3,300,000 3,300,000 3,300,000        
SO 2025-2                        
Shareholders' equity                        
Fair value per SO at grant date | €                   € 1.78    
Outstanding at beginning of period           6,000,000            
Outstanding at end of period           6,000,000            
Implied stock options fair values | € € 10,700,000   € 10,700,000 € 10,700,000 € 10,700,000 € 10,700,000 € 10,700,000 € 10,700,000        
SO 2025-3                        
Shareholders' equity                        
Vesting period (year)     3 years                  
Holding period (year)     1 year                  
Number of shares per SO | shares 1   1 1 1 1 1 1        
Expected volatility             57.30%          
Average life (years) | Y               5        
Risk-free rate             2.70%          
Fair value per SO at grant date | € € 3.68   € 3.68 € 3.68 € 3.68 € 3.68 € 3.68 € 3.68 € 3.68      
Share price | € / shares       € 3.63                
Outstanding at beginning of period           1,145,500            
Issued           1,145,500            
Outstanding at end of period           1,145,500            
Implied stock options fair values | € € 4,200,000   € 4,200,000 € 4,200,000 € 4,200,000 € 4,200,000 € 4,200,000 € 4,200,000        
SO 2026-1                        
Shareholders' equity                        
Vesting period (year)     3 years                  
Holding period (year)     1 year                  
Number of shares per SO | shares 1   1 1 1 1 1 1        
Expected volatility             59.00%          
Average life (years) | Y               5        
Risk-free rate             3.10%          
Fair value per SO at grant date | € € 1.68 € 1.68 € 1.68 € 1.68 € 1.68 € 1.68 € 1.68 € 1.68        
Share price | € / shares       € 3.26                
Issued   1,067,000       1,067,000            
Outstanding at end of period           1,067,000            
Implied stock options fair values | € € 1,800,000   € 1,800,000 € 1,800,000 € 1,800,000 € 1,800,000 € 1,800,000 € 1,800,000        
SO 2026-1 | Employees                        
Shareholders' equity                        
Issued | shares   517,000                    
SO 2026-1 | Pamela Herbster, Chief People Officer                        
Shareholders' equity                        
Issued | shares   550,000                    
SO 2026-2                        
Shareholders' equity                        
Vesting period (year)     1 year 6 months                  
Holding period (year)     1 year                  
Number of shares per SO | shares 1   1 1 1 1 1 1        
Expected volatility             58.70%          
Average life (years) | Y               5        
Risk-free rate             3.10%          
Fair value per SO at grant date | € € 1.83   € 1.83 € 1.83 € 1.83 € 1.83 € 1.83 € 1.83        
Share price | € / shares       € 3.33                
Issued           3,000,000            
Outstanding at end of period           3,000,000            
Implied stock options fair values | € € 5,500,000   € 5,500,000 € 5,500,000 5,500,000 € 5,500,000 € 5,500,000 € 5,500,000        
Share-based compensation expense | €         € 0              
SO 2026-2 | Mark Pruzanski, Chairman of the Board of Directors                        
Shareholders' equity                        
Issued | shares 3,000,000